MedicarePartD.guide

A non-government resource built from CMS public data

Mavyret on AARP Medicare Rx Preferred from UHC (S5921-389)

glecaprevir and pibrentasvir

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 84 per 28 days.

$4,329.63
Patient pays / month, after deductible
$4,419.33
Patient pays / month, before the $130.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

MAVYRET 40/100 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $13,966.54 for a month. Other covered strengths are listed below.

Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
FormTierPatient pays / monthLimits
MAVYRET 20/50 mg Pellet5$4,570.99PA · 140 per 28 days
MAVYRET 40/100 mg Tablet, Film Coated5$4,329.63PA · 84 per 28 days

Other Hepatitis C drugs on this plan

Verify with the plan before prescribing or filling. Member services: (866)870-3470. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5921-389